健康元(600380.SH)擬推中長期事業合夥人持股計劃之第二期持股計劃
格隆匯4月24日丨健康元(600380.SH)發佈中長期事業合夥人持股計劃之第二期持股計劃(草案),公司員工參與本期持股計劃的資金來源為公司計提的2021年度持股計劃專項基金。本期持股計劃的資金總額為7576萬元,全部為公司計提的激勵基金。
本期持股計劃的參與對象為:在公司任職的高級管理人員、對考核期業績有突出貢獻或對公司未來業績有重大影響的研發、生產、銷售、管理等核心人員。本期持股計劃總人數不超過50人,其中參與本期持股計劃的董事(不含獨立董事)和高級管理人員共計4人,最終參與人員根據實際認購情況確定。
本期持股計劃股票來源為:通過二級市場購買(包括但不限於競價交易、大宗交易等方式)等法律法規許可的方式購買的標的股票。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.